Patent ID: 9468611
Filing Date: 2016-10-18
CPC Classification: A61K,A61P

Claim Text:
1. A method of treating psychological and psychiatric symptoms comprising: administering a composition to a subject suffering from one or more psychological symptoms chosen from depression, anxiety, fatigue, and mood instability including pseudo-bulbar affect, the composition including, as the sole active agent for treating said one or more psychological symptoms, an NMDA receptor antagonist selected from d-methadone, d-methadol, d-alpha-acetylmethadol, d-alpha-normethadol, l-alpha-normethadol, and pharmaceutically acceptable salts thereof; wherein the NMDA receptor antagonist is isolated from its enantiomer or synthesized de novo; and wherein the administering of the composition occurs under conditions effective for the NMDA receptor antagonist to bind to an NMDA receptor of the subject and thereby relieve the subject from said one or more psychological symptoms.